NCT06052852 2025-11-17Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesBolt Biotherapeutics, Inc.Phase 1 Terminated17 enrolled
NCT05846646 2025-10-20Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCCImmuneSensor Therapeutics Inc.Phase 2 Terminated6 enrolled 7 charts